NCT02169349View on ClinicalTrials.gov

Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

September 30, 2016

Conditions
Stage IIIb and IV Non Small Cell Lung Cancer
Interventions
OTHER

laboratory biomarker analysis

OTHER

Next Generation Sequencing

GENETIC

DNA Analysis

Trial Locations (1)

35000

CHU, Rennes

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Rennes University Hospital

OTHER

NCT02169349 - Molecular Diagnosis on Circulating Tumor DNA of Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter